DDMAC Slamming The Door On Open-Label Studies In Promotions
This article was originally published in The Pink Sheet Daily
Executive Summary
Nycomed gets a "notice of violation" letter for a flashcard that used open-label study data to make claims for its actinic keratoses treatment Solaraze (diclofenac).